Literature DB >> 30610353

Comment to Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials.

Christiane Matuschek1, David Krug2,3,4, Rainer J Klement5, René Baumann6,4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30610353     DOI： 10.1007/s00066-018-1411-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  10 in total

1.  Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease : An individual patient data analysis of three clinical trials.

Authors:  Omar Abdel-Rahman
Journal:  Strahlenther Onkol       Date:  2018-08-01       Impact factor: 3.621

2.  Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.

Authors:  Wolfgang Eiermann; Tadeusz Pienkowski; John Crown; Saeed Sadeghi; Miguel Martin; Arlene Chan; Mansoor Saleh; Sandeep Sehdev; Louise Provencher; Vladimir Semiglazov; Michael Press; Guido Sauter; Mary-Ann Lindsay; Alessandro Riva; Marc Buyse; Philippe Drevot; Henry Taupin; John R Mackey
Journal:  J Clin Oncol       Date:  2011-09-12       Impact factor: 44.544

3.  Regional Nodal Irradiation in Early-Stage Breast Cancer.

Authors:  Timothy J Whelan; Ivo A Olivotto; Wendy R Parulekar; Ida Ackerman; Boon H Chua; Abdenour Nabid; Katherine A Vallis; Julia R White; Pierre Rousseau; Andre Fortin; Lori J Pierce; Lee Manchul; Susan Chafe; Maureen C Nolan; Peter Craighead; Julie Bowen; David R McCready; Kathleen I Pritchard; Karen Gelmon; Yvonne Murray; Judy-Anne W Chapman; Bingshu E Chen; Mark N Levine
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

4.  Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.

Authors:  Philip M Poortmans; Sandra Collette; Carine Kirkove; Erik Van Limbergen; Volker Budach; Henk Struikmans; Laurence Collette; Alain Fourquet; Philippe Maingon; Mariacarla Valli; Karin De Winter; Simone Marnitz; Isabelle Barillot; Luciano Scandolaro; Ernest Vonk; Carla Rodenhuis; Hugo Marsiglia; Nicola Weidner; Geertjan van Tienhoven; Christoph Glanzmann; Abraham Kuten; Rodrigo Arriagada; Harry Bartelink; Walter Van den Bogaert
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

5.  Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.

Authors:  John R Mackey; Miguel Martin; Tadeusz Pienkowski; Janusz Rolski; Jean-Paul Guastalla; Amer Sami; John Glaspy; Eva Juhos; Andrew Wardley; Tommy Fornander; John Hainsworth; Robert Coleman; Manuel R Modiano; Jeferson Vinholes; Tamas Pinter; Alvaro Rodríguez-Lescure; Bruce Colwell; Pierre Whitlock; Louise Provencher; Kara Laing; David Walde; Chris Price; Judith C Hugh; Barrett H Childs; Kimberly Bassi; Mary-Ann Lindsay; Véronique Wilson; Matthieu Rupin; Vincent Houé; Charles Vogel
Journal:  Lancet Oncol       Date:  2012-12-12       Impact factor: 41.316

6.  Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.

Authors:  Andrew McBride; Pamela Allen; Wendy Woodward; Michelle Kim; Henry M Kuerer; Eva Katherine Drinka; Aysegul Sahin; Eric A Strom; Aman Buzdar; Vicente Valero; Gabriel N Hortobagyi; Kelly K Hunt; Thomas A Buchholz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-07       Impact factor: 7.038

7.  Impact of smoking history on the outcomes of women with early-stage breast cancer: a secondary analysis of a randomized study.

Authors:  Omar Abdel-Rahman; Winson Y Cheung
Journal:  Med Oncol       Date:  2018-04-11       Impact factor: 3.064

8.  Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.

Authors:  Lynnette Fernández-Cuesta; Catherine Oakman; Priscila Falagan-Lotsch; Ke-Seay Smoth; Emmanuel Quinaux; Marc Buyse; M Stella Dolci; Evandro De Azambuja; Pierre Hainaut; Patrizia Dell'orto; Denis Larsimont; Prudence A Francis; John Crown; Martine Piccart-Gebhart; Giuseppe Viale; Angelo Di Leo; Magali Olivier
Journal:  Breast Cancer Res       Date:  2012-05-02       Impact factor: 6.466

9.  Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update.

Authors:  Wilfried Budach; Edwin Bölke; Kai Kammers; Peter Arne Gerber; Carolin Nestle-Krämling; Christiane Matuschek
Journal:  Radiat Oncol       Date:  2015-12-21       Impact factor: 3.481

10.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

Authors:  P McGale; C Taylor; C Correa; D Cutter; F Duane; M Ewertz; R Gray; G Mannu; R Peto; T Whelan; Y Wang; Z Wang; S Darby
Journal:  Lancet       Date:  2014-03-19       Impact factor: 79.321
  10 in total
  1 in total

1.  Impact of Adjuvant Radiation Therapy in Patients With Male Breast Cancer: A Multicenter International Analysis.

Authors:  Daniel Rolf; Khaled Elsayad; Mohamed A M Meheissen; Yasser Elkerm; Carl Opitz; Isabel Radke; Anne Bremer; Anne Hülskamp; Rasha Elsaka; Horeya M Ismail; Essam Elfaham; Abdelsalam Attia Ismail; Hazem Elmansy; Eva Wardelmann; Amr Abdelaziz Elsaid; Barbara Krause-Bergmann; Joke Tio; Hans Theodor Eich; Oliver Micke
Journal:  Adv Radiat Oncol       Date:  2020-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.